| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |